Sale!

COL6A2 Gene Ullrich Congenital Muscular Dystrophy Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COL6A2 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the COL6A2 gene responsible for Ullrich congenital muscular dystrophy. This comprehensive test utilizes next-generation sequencing technology to provide accurate detection of genetic variations associated with this rare neuromuscular disorder. The test is essential for individuals experiencing muscle weakness, joint contractures, or respiratory complications from early childhood. Early diagnosis through this test enables proper management strategies and treatment planning. Available for $500 USD, this test provides crucial genetic information for affected individuals and their families. Our advanced NGS methodology ensures high sensitivity and specificity in detecting COL6A2 gene mutations. The test requires a simple blood sample or extracted DNA and delivers results within 3-4 weeks. Genetic counseling is recommended before testing to understand familial implications and create comprehensive pedigree analysis.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COL6A2 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Neuromuscular Disorders

The COL6A2 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test represents a breakthrough in diagnostic precision for individuals affected by this rare inherited neuromuscular condition. Utilizing state-of-the-art next-generation sequencing technology, this test provides definitive genetic confirmation of Ullrich congenital muscular dystrophy by identifying pathogenic mutations in the COL6A2 gene. Early and accurate diagnosis is crucial for implementing appropriate management strategies and improving quality of life for affected individuals.

What Does This Test Detect?

This advanced genetic test specifically targets mutations in the COL6A2 gene, which encodes collagen type VI alpha 2 chain – a critical component of the extracellular matrix in muscle tissue. The test identifies:

  • Point mutations, deletions, and insertions in the COL6A2 gene
  • Pathogenic variants affecting collagen VI production and function
  • Genetic alterations responsible for disrupted muscle fiber integrity
  • Inheritance patterns for family planning considerations

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with symptoms suggestive of Ullrich congenital muscular dystrophy, including:

  • Infants and children with congenital muscle weakness and hypotonia
  • Individuals with progressive muscle weakness starting in early childhood
  • Patients with joint contractures, particularly in elbows and ankles
  • Those experiencing respiratory complications and scoliosis
  • Individuals with hyperlaxity of distal joints alongside proximal contractures
  • Family members of diagnosed individuals for carrier testing

Clinical Benefits of Genetic Testing

Undergoing the COL6A2 gene test provides numerous advantages for patients and healthcare providers:

  • Definitive Diagnosis: Confirms or rules out Ullrich congenital muscular dystrophy with high accuracy
  • Personalized Management: Enables tailored treatment plans based on specific genetic findings
  • Family Planning: Provides crucial information for reproductive decision-making
  • Early Intervention: Facilitates timely implementation of physical therapy and respiratory support
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Advances understanding of collagen VI-related disorders

Understanding Your Test Results

Our comprehensive genetic report provides detailed interpretation of your COL6A2 gene analysis:

  • Positive Result: Indicates the presence of pathogenic mutations confirming Ullrich congenital muscular dystrophy diagnosis
  • Negative Result: Suggests absence of detectable COL6A2 mutations, though clinical correlation is essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
  • Carrier Status: Determines if individuals carry one copy of mutated gene without disease manifestation

All results are accompanied by detailed explanations and recommendations for follow-up care. Genetic counseling is strongly recommended to fully understand the implications of your test results.

Test Pricing Information

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly offer the COL6A2 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test across all major cities in the United States. Our state-of-the-art testing facilities are conveniently located in:

  • New York City and surrounding metropolitan areas
  • Los Angeles and Southern California regions
  • Chicago and Midwest locations
  • Houston, Dallas, and Texas facilities
  • Phoenix, Arizona testing centers
  • And numerous additional locations nationwide

Our network of certified genetic counselors and neurological specialists ensures comprehensive pre-test and post-test support throughout your diagnostic journey.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neuromuscular symptoms delay proper diagnosis and treatment. Our COL6A2 gene test provides the definitive answers you need to make informed healthcare decisions. With results delivered within 3-4 weeks and simple sample collection (blood or extracted DNA), getting tested has never been more accessible.

Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take control of your genetic health with confidence and precision.